2019\u5e749\u67082\u65e5<\/p>\n
Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva) \u306f\u3001Novartis\u793e\u524dCEO\u306eJoe Jimenez\u6c0f\u3068Eli Lilly and Company\u793e\u533b\u85ac\u54c1\u958b\u767a\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eRob Metcalf\u6c0f\u304c\u30012019 Veeva R&D Summit<\/a><\/strong>\u306b\u57fa\u8abf\u8b1b\u6f14\u8005\u3068\u3057\u3066\u767b\u58c7\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u4e21\u6c0f\u306b\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u306e\u9769\u65b0\u7684\u306a\u5275\u85ac\u306b\u304a\u3051\u308b\u6700\u5148\u7aef\u3067\u6d3b\u8e8d\u3059\u308b\u30d3\u30b8\u30e7\u30ca\u30ea\u30fc\u3068\u3057\u3066\u3001\u696d\u754c\u5168\u4f53\u3067\u88fd\u54c1\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u308b\u6a5f\u4f1a\u306b\u3064\u3044\u3066\u8b1b\u6f14\u3057\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n Metcalf\u6c0f\u306f9\u67089\u65e5\u6708\u66dc\u65e5\u306b\u767b\u58c7\u3057\u3001\u5927\u624b\u88fd\u85ac\u4f01\u696d\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u7d44\u7e54\u306e\u904b\u55b6\u306e\u8907\u96d1\u3055\u3068\u305d\u306e\u7d4c\u9a13\u304b\u3089\u5b66\u3093\u3060\u3053\u3068\u306b\u3064\u3044\u3066\u8a9e\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u3069\u306e\u3088\u3046\u306b\u9769\u65b0\u7684\u306a\u79d1\u5b66\u6280\u8853\u306e\u63d0\u4f9b\u3092\u8fc5\u901f\u5316\u3057\u3001\u9069\u5207\u306a\u533b\u85ac\u54c1\u3092\u9069\u5207\u306a\u60a3\u8005\u306b\u5b89\u5168\u304b\u3064\u52b9\u7387\u7684\u306b\u5c4a\u3051\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n \u706b\u66dc\u65e5\u306b\u306f\u3001\u305d\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u53d6\u308a\u7d44\u307f\u306b\u3088\u3063\u3066Novartis\u793e\u306b\u696d\u754c\u6700\u5927\u898f\u6a21\u306e\u81ea\u793e\u5275\u85ac\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u3082\u305f\u3089\u3057\u305fJimenez\u6c0f\u304c\u767b\u58c7\u3057\u3001\u7570\u7a2e\u79fb\u690d\u306b\u91cd\u70b9\u7684\u306b\u53d6\u308a\u7d44\u3080\u6700\u5148\u7aef\u30d0\u30a4\u30aa\u4f01\u696d\u3067\u3042\u308beGenesis\u793eCEO\u306ePaul Sehkri\u6c0f\u3068\u3068\u3082\u306b\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u304a\u3051\u308b\u60a3\u8005\u3078\u306e\u8ca2\u732e\u3084\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u7814\u7a76\u958b\u767a\u306a\u3069\u3078\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u30a4\u30f3\u30d1\u30af\u30c8\u306b\u3064\u3044\u3066\u3001\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n \u3055\u3089\u306b\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u3001\u533b\u7642\u6a5f\u5668\u4f01\u696d\u304a\u3088\u3073\u8a3a\u65ad\u85ac\u4f01\u696d\u304b\u308955\u4eba\u4ee5\u4e0a\u304c\u3001Veeva\u306e\u81e8\u5e8a\u958b\u767a\u30fb\u85ac\u4e8b\u30fb\u54c1\u8cea\u696d\u52d9\u7528\u7d71\u5408\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u88fd\u54c1\u958b\u767a\u3092\u8fc5\u901f\u5316\u3057\u305f\u3001\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002\u6ce8\u76ee\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u306f\u4e0b\u8a18\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n 2019 Veeva R&D Summit\u306f\u30012019\u5e749\u67088\uff5e10\u65e5\u306b\u30da\u30f3\u30b7\u30eb\u30d9\u30cb\u30a2\u5dde\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u30021,700\u4eba\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3084\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306e\u53c2\u52a0\u304c\u898b\u8fbc\u307e\u308c\u3066\u3044\u308b\u307b\u304b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3092\u727d\u5f15\u3059\u308b\u4f01\u696d\u306b\u3088\u308b75\u4ee5\u4e0a\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n Agios\u793e\u3001Alkermes\u793e\u3001Allergan\u793e\u3001Amgen\u793e\u3001Amicus Therapeutics\u793e\u3001Bioforum\u793e\u3001BioMarin Pharmaceutical\u793e\u3001Blueprint Medicines\u793e\u3001Bristol-Myers Squibb\u793e\u3001Cara Therapeutics\u793e\u3001Celularity\u793e\u3001\u7b2c\u4e00\u4e09\u5171\u793e\u3001Dicerna Pharmaceuticals\u793e\u3001\u30a8\u30fc\u30b6\u30a4\u793e\u3001Eli Lilly and Company\u793e\u3001Foamix Pharmaceuticals\u793e\u3001Gilead\u793e\u3001Global Blood Therapeutics\u793e\u3001Insmed\u793e\u3001Janssen\u793e\u3001Lotus Pharmaceutical\u793e\u3001Melinta Therapeutics\u793e\u3001Merck Healthcare KGaA\u793e\u3001Myovant Sciences\u793e\u3001Penumbra\u793e\u3001PRA Health Sciences\u793e\u3001REGENXBIO\u793e\u3001Roche Diagnostics\u793e\u3001Sarah Cannon Research Institute\u793e\u3001TESARO\u793e\uff08\u00a0a GSK Company\uff09\u3001Louisville\u5927\u5b66\u3001Vericel\u793e\u3001Xencor\u793e\u3001Xeris Pharma\u793e<\/p>\n 2019 Veeva R&D Summit\u306e\u30d7\u30e9\u30c1\u30ca\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAccenture\u793e\u3001Amazon Web Services\u793e, Kinapse\u793e\u3001NNIT\u793e\u3001PWC\u793e\u3001\u304a\u3088\u3073Valiance\u793e\u3067\u3059\u3002\u30b4\u30fc\u30eb\u30c9\u30b9\u30dd\u30f3\u30b5\u30fc\u306fCGI\u793e\u3001Daelight Solutions\u793e\u3001Deloitte\u793e\u3001Eagle Productivity\u793e\u3001FME\u793e\u3001GenPact\u793e\u3001C3i Solutions\u793e\u3001LMK Clinical\u793e\u3001Ideagen PLC\u793e\u3001LPW Training Services\u793e\u3001MuleSoft\u793e\u3001SDL\u793e\u3001\u304a\u3088\u3073Trifecta\u793e\u3067\u3059\u3002\u30b7\u30eb\u30d0\u30fc\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAppBus\u793e\u3001Base Life Sciences\u793e\u3001OnTheMove\u793e\u3001Pyxa Solutions\u793e\u3001\u304a\u3088\u3073Suvoda\u793e\u3067\u3059\u3002<\/p>\n Veeva R&D Summit\u306f\u3001Veeva\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u69d8\u5411\u3051\u306e\u7121\u6599\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u3001\u3054\u767b\u9332\u3001\u8a73\u3057\u3044\u30a2\u30b8\u30a7\u30f3\u30c0\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/R&DSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n <\/p>\n \u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e749\u67082\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-42873","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42873"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42873"}],"version-history":[{"count":3,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42873\/revisions"}],"predecessor-version":[{"id":42877,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42873\/revisions\/42877"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067775\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended April 30, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"